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Synthetic tools for studying the chemical biology
of InsP8†
Andrew M. Riley,a Huanchen Wang,b Stephen B. Shearsb and Barry V. L. Potter*ac
To synthesise stabilised mimics of InsP8, the most phosphorylated
inositol phosphate signalling molecule in Nature, we replaced its
two diphosphate (PP) groups with either phosphonoacetate (PA) or
methylenebisphosphonate (PCP) groups. Utility of the PA and PCP
analogues was verified by structural and biochemical analyses of
their interactions with enzymes of InsP8 metabolism.
Themyo-inositol phosphates (InsPs) are a family of intracellular
signalling molecules containing combinatorial arrangements
of monophosphate (P) and diphosphate (PP) groups arranged
around the hexahydroxycyclohexane ring of myo-inositol (Ins).1
There is much current interest in the specialised chemistry and
biology of the diphosphoinositol polyphosphates (PP-InsPs,
inositol pyrophosphates);2 recent research has highlighted the
central roles that PP-InsPs play in cellular and organismic
homeostasis in all eukaryotes. For example, PP-InsPs regulate
DNA repair,3 immunity4,5 and metabolic homeostasis.6–8
Themost studied of the PP-InsPs are 5-InsP7, 1-InsP7 and InsP8
(Fig. 1), which are formed from InsP6 by InsP6 kinases (IP6Ks) and
diphosphoinositol pentakisphosphate kinases (PPIP5Ks).9 The
diphosphate groups that are produced by IP6K and PPIP5K are
hydrolysed by a family of PP-InsP diphosphohydrolases (DIPPs),
leaving monophosphate groups and liberating inorganic ortho-
phosphate (Pi).10
Evidence has been obtained that the PP-InsPs non-enzymatically
pyrophosphorylate a range of target proteins.11 It has also been
reported that 5-InsP7 produces a separate range of cellular
eﬀects by interacting with pleckstrin homology (PH) domains
of proteins.12 Additionally, in response to viral invasion, 1-InsP7
was recently shown to stimulate phosphorylation of IRF3, an
activator of interferon transcription.5 No independent function for
InsP8 has, however, yet been shown. Nevertheless, in mammalian
cells, levels of InsP8 are regulated in a stimulus-dependent
fashion, increasing several-fold following osmotic stress or
thermal challenge,13 whereas bioenergetic stress decreases
InsP8 concentrations.
7 Indeed, InsP8 is the only PP-InsP so far
shown to exhibit such acute, stimulus-dependent changes in
Fig. 1 (a) Biosynthesis of diphosphoinositol polyphosphates from myo-
inositol hexakisphosphate (InsP6). IP6K, inositol hexakisphosphate 5-kinase;
PPIP5K, diphosphoinositol pentakisphosphate kinase; DIPP, diphospho-
inositol polyphosphate phosphohydrolase; (b) structures of synthetic
a-phosphonoacetic acid ester (PA) analogue 1 and methylenebisphosphonate
(PCP) analogue 2.
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its levels. Such responses are typically hallmarks of a signalling
event, in which the concentration-dependent influence of a
messenger upon a target protein (a receptor) is transduced into
a biological response. It is therefore reasonable to consider the
existence of InsP8 ‘‘receptors’’.
The structure of mammalian InsP8 has been identified
14,15 as
1,5-[PP]2-InsP4 (Fig. 1) and a chemical synthesis
16 has provided
isomerically pure material in the amounts required for detailed
biological studies with cell extracts. However, in such experi-
ments, the PP-InsPs are rapidly metabolised by phosphatases.
Therefore, there is a need for synthetic InsP8-based probes,
especially stabilised analogues in which the labile diphosphate
(PP) is replaced with mimics more resistant to chemical and
enzymatic degradation. Such compounds could be used to
screen for InsP8 receptors in cellular or tissue lysates and may
have greater potential for further synthetic elaboration than
InsP8 itself. They may also be useful as mechanistic probes
because they cannot substitute for the ability of InsP8 to transfer
a phosphate group to target proteins.11
Previously, we reported the syntheses of analogues of 5-InsP7,
in which the PP group is replaced with an a-phosphonoacetic acid
(PA) ester.17 Others have developed methylenebisphosphonate
(PCP) analogues of 1- and 5-InsP7.
18 The synthesis of the corre-
sponding InsP8 mimics is considerably more challenging, requir-
ing introduction of two PP surrogates around an asymmetrically
substituted myo-inositol hub of known absolute configuration.
Here we report the syntheses of the PA and PCP analogues of InsP8,
namely, 1,5-[PA]2-InsP4 (1) and 1,5-[PCP]2-InsP4 (2), respectively.
The syntheses of 1 and 2 (Scheme 1) begins with diol ()-3,
obtained by regioselective reduction of 2,4,6-tri-O-benzyl myo-
inositol orthobenzoate,19 followed by optical resolution of racemic
3 via the formation of diastereoisomeric monocamphanate esters20
(see ESI† for details).‡ For the synthesis of 1,5-[PA]2-InsP4 (1),
carbodiimide-mediated esterification of the two free hydroxyl
groups in ()-3 with diethylphosphonoacetic acid (4) proceeded
smoothly to give diester 5. Hydrogenolytic cleavage of the
benzyl protecting groups allowed isolation of tetraol 6, while
avoiding the facile ester 1,2-migration. Phosphitylation of the
exposed hydroxyl groups at C-2, C-3, C-4 and C-6 using bis(benzyloxy)-
diisopropylaminophosphine, followed by oxidation gave 7. Treatment
with TMSBr removed benzyl and ethyl ester protecting groups on
phosphates and phosphonates respectively to give the per-silylated
intermediate. Finally, cleavage of silyl esters with methanol followed
by a simple work-up with aqueous triethylammonium bicarbonate
gave 1,5-[PA]2-InsP4 (1) as the triethylammonium salt.§
The synthesis of 1,5-[PCP]2-InsP4 (2) from ()-3 was more
challenging than the analogous synthesis of 1, essentially due to
two complicating factors. First, introduction of two tri-protected
PCP moieties at O-1 and O-5 of ()-3 results in the formation of
stereogenic centres at P-1 and P-5. The required product will
therefore consist of a mixture of four diastereoisomers.
Second, phosphonylation of the sterically hindered secondary
hydroxyl groups in ()-3 proved to bemuchmore diﬃcult than their
acylation. Initial attempts at carbodiimide-mediated condensation
of ()-3 with the triethyl ester of methylenebisphosphonic acid (8)
gave no product. Reaction of ()-3 with the phosphonochloridate
derived from 8 in pyridine gave only the 1-bisphosphonate as a
mixture of two diastereoisomers. Trials using this phosphono-
chloridate with other bases and solvents gave the desired product 9,
but only in unacceptably low yields. More promising results were
obtained usingDIPEA in dichloromethane;¶ under these conditions,
9 was obtained in 15% yield after flash chromatography, together
with larger amounts of monophosphonylated material (in this case,
a mixture of 1- and 5-bisphosphonates), which could be recycled to
givemore 9. In this way, 9was obtained as an inseparablemixture of
four diastereoisomers (ratio approx. 3 :3 :1 :1 by NMR) in a total
yield of 30% after one round of recycling. Further recycling to give
more 9 was possible, but was not carried out.
Scheme 1 Synthesis of 1 and 2. Reagents and conditions: (a) EDAC, 4, CH2Cl2; (b) H2, Pd(OH)2/C, MeOH, H2O; (c) i. (BnO)2PNPr
i
2, 5-phenyl-1H-
tetrazole, CH2Cl2; ii.mCPBA, CH2Cl2; (d) i. TMSBr, CH2Cl2; ii. MeOH, TEAB; (e) (EtO)2P(O)CH2P(O)(OEt)Cl, DIPEA, CH2Cl2; (f) H2, Pd(OH)2/C, MeOH, THF,
H2O, AcOH. TEAB, aqueous triethylammonium bicarbonate; Bn, benzyl. Yields are shown in respect of each step. Stereogenic phosphorus atoms are
indicated by an asterisk.
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Removal of the benzyl protecting groups from 9 followed by
phosphitylation and oxidation gave fully protected 10, again as
a mixture of four diastereoisomers. The NMR spectra of 10 were
highly complex, with at least 30 lines in the 31P NMR spectrum
(see ESI†). However, on global deprotection with TMSBr followed
by cleavage of silyl esters with methanol, the stereogenic centres at
phosphorus were abolished, at last revealing the expected pattern
of NMR signals for 1,5-[PCP]2-InsP4 (2), which was isolated as the
triethylammonium salt after ion-exchange chromatography.
When we incubated either InsP8 analogue 1 or 2 with DIPP,
we did not detect any Pi release. Next, we examined the inter-
actions of 1 and 2 with the highly specific kinase domain of
human PPIP5K2 (PPIP5K2KD). We have previously found that the
reaction catalysed by PPIP5K2KD is reversible in vitro, yielding
ATP when PPIP5K2KD is incubated with ADP and InsP8.
21
Detection of the generated ATP with luciferin/luciferase provides
a sensitive assay for the reverse kinase reaction.17,21,22 No ATP
was detected using 1 or 2 in these assays (data not shown).
Previously,15 we obtained enzyme-product complexes by
soaking InsP8 into crystals of PPIP5K2
KD containing ADP. In
the present work, we soaked product analogues 1 and 2 into
similarly prepared crystals of PPIP5K2KD. X-ray analyses showed
that both compounds bound to the catalytic site of PPIP5K2KD
(Fig. 2). Significantly, the PA-containing analogue 1 was also
observed in a second binding site, the function of which was
previously demonstrated to enhance capture of substrate from
the bulk phase.22 In this respect, compound 2 more closely
mimics natural InsP8, which was also found to occupy exclu-
sively the catalytic site.15,16 This should not be taken to mean
that InsP8 and 2 do not also bind to the capture site but that,
presumably, they occupy it only transiently. Thus, the PA
compound 1 provides additional insights into a subsequent
step of the catalytic cycle; the transfer of newly-formed InsP8 to
the capture site prior to release. Notably, the 1-PA group of 1 is
solvent-exposed and has no interactions with the capture/
release site. This is consistent with the requirement that the
site must bind both substrate (without 1-PP) and product (with
1-PP); it also suggests a suitable attachment point for reporter
groups in probes designed to target this site.
In conclusion, we report the syntheses of two stabilised
analogues of InsP8; 1,5-[PA]2-InsP4 (1) and 1,5-[PCP]2-InsP4 (2).
Our observation that the PA analogue 1 occupies the capture/
release site in PPIP5K2 reveals how InsP8 mimics can give
insight into diﬀerent enzyme states within the overall catalytic
cycle. Stabilised mimics will also be useful for identifying
receptors within cell lysates. Since these two new probes might
interact with receptors in subtly diﬀerent ways, the use of both
may increase opportunities to capture InsP8 receptors. The
diﬀering and complementary interactions of 1 and 2 with
PPIPK2 (Fig. 2) illustrate this point.
Cellular levels of InsP8 are subject to stimulus-dependent
regulation, yet it remains an orphan signal; no specific InsP8
receptor has yet been identified. Nevertheless, InsP8, which
possesses the most crowded array of phosphate groups in
Nature, demands from the cell a significant investment in
energy to sustain its levels against a backdrop of high ongoing
turnover. With recent advances in delivering PP-InsPs (and
hence PP-InsP mimics) into cells,23 it should now become
possible to screen for biological eﬀects of InsP8, and InsP8
mimics, in intact cells.
B.V.L.P. is a Wellcome Trust Senior Investigator (Grant
101010). This research was also supported by the Intramural
Fig. 2 Refined 2Fo–Fc maps contoured at 1.0 s for both compounds (top) and simulated annealing omit maps (Fo–Fc, bottom panels) contoured at 2.0 s
for 1,5-[PA]2-InsP4 (1) and 3.0 for 1,5-[PCP]2-InsP4 (2). Compounds are shown as stick models. Carbon atoms are shown in cyan (1) or green (2), oxygen
atoms in red, nitrogen atoms in blue, and phosphorus atoms in orange. The protein is shown as a surface representation.
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